现代板层角膜移植(DALK、DSAEK、DMEK)与常规穿透性角膜移植后的免疫反应
本综述描述了穿透性角膜移植(PK)、深前板层角膜移植(DALK)、自动板层刀辅助后板层角膜移植(DSAEK)和角膜内皮移植(DMEK)的技术、适应证、并发症与结局,并概述角膜移植免疫学,重点讨论内皮型移植排斥的发生率、临床表现及当前和未来的治疗与预防选择。
要点
- DALK消除了内皮型同种异体移植排斥的可能性,而PK后移植失败的主要原因正是内皮型排斥。
- 与PK相比,DSAEK/DMEK后内皮型移植排斥的风险显著降低。
- 在低风险情况下,现代板层技术似乎已近乎解决内皮型移植排斥的临床问题,但板层移植仍可发生上皮、上皮下和基质免疫反应(DALK)及内皮免疫反应(DSAEK/DMEK),且并非所有角膜移植都能以板层方式完成。
核心结论
- 在低风险情况下,现代板层技术似乎已近乎解决内皮型移植排斥的临床问题;但PK中的内皮型移植排斥仍然高度相关,尤其是在高风险情况下,目前可用的治疗方案仍不令人满意。
研究设计与样本
- 综述,描述了PK、DALK、DSAEK和DMEK技术及其适应证、手术描述、并发症和结局,并概述角膜移植免疫学。
主要发现
- DALK消除了内皮型同种异体移植排斥的可能性,而内皮型排斥是PK后移植失败的主要原因。
- 与PK相比,DSAEK/DMEK后内皮型移植排斥的风险显著降低。
- 即使使用板层移植,DALK中仍存在上皮、上皮下和基质免疫反应,DSAEK/DMEK中存在内皮免疫反应。
- 并非所有角膜移植都能以板层方式完成;在严重炎症和病理性新生血管导致角膜(淋巴)血管生成和免疫特权丧失的高风险情况下,PK中的内皮型移植排斥仍然高度相关,目前可用的治疗方案仍不令人满意。
关键数值与推荐
- DALK消除了内皮型同种异体移植排斥的可能性,而内皮型排斥是PK后移植失败的主要原因。
- 与PK相比,DSAEK/DMEK后内皮型移植排斥的风险显著降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the past decade, novel lamellar keratoplasty techniques such as Deep Anterior Lamellar Keratoplasty (DALK) for anterior keratoplasty and Descemet stripping automated endothelial keratoplasty (DSAEK)/Descemet membrane endothelial keratoplasty (DMEK) for posterior keratoplasty have been developed. DALK eliminates the possibility of endothelial allograft rejection, which is the main reason for graft failure after penetrating keratoplasty (PK). Compared to PK, the risk of endothelial graft rejection is significantly reduced after DSAEK/DMEK. Thus, with modern lamellar techniques, the clinical problem of endothelial graft rejection seems to be nearly solved in the low-risk situation. However, even with lamellar grafts there are epithelial, subepithelial and stromal immune reactions in DALK and endothelial immune reactions in DSAEK/DMEK, and not all keratoplasties can be performed in a lamellar fashion. Therefore, endothelial graft rejection in PK is still highly relevant, especially in the "high-risk" setting, where the cornea's (lymph)angiogenic and immune privilege is lost due to severe inflammation and pathological neovascularization. For these eyes, currently available treatment options are still unsatisfactory. In this review, we will describe currently used keratoplasty techniques, namely PK, DALK, DSAEK, and DMEK. We will summarize their indications, provide surgical descriptions, and comment on their complications and outcomes. Furthermore, we will give an overview on corneal transplant immunology. A specific focus will be placed on endothelial graft rejection and we will report on its incidence, clinical presentation, and current/future treatment and prevention options. Finally, we will speculate how the field of keratoplasty and prevention of corneal allograft rejection will develop in the future.
引用
- Hos D, Matthaei M, Bock F, et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019. PMID: 31279005. doi:10.1016/j.preteyeres.2019.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。